Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models

SIMPLE SUMMARY: The fact that most endometrial cancer (EC) patients overexpress the CXCR4 receptor in tumor tissue, especially at incurable advanced stages, opens an avenue for developing novel therapies targeting CXCR4(+) EC cells to add new armamentarium against this malignancy. We have generated...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina-Gutiérrez, Esperanza, García-León, Annabel, Gallardo, Alberto, Álamo, Patricia, Alba-Castellón, Lorena, Unzueta, Ugutz, Villaverde, Antonio, Vázquez, Esther, Casanova, Isolda, Mangues, Ramon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818013/
https://www.ncbi.nlm.nih.gov/pubmed/36612081
http://dx.doi.org/10.3390/cancers15010085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818013/
https://www.ncbi.nlm.nih.gov/pubmed/36612081
http://dx.doi.org/10.3390/cancers15010085

Ejemplares similares